Connect with us

Health

Entrenched positions likely to mark second critical medicines trilogue

SHARE:

Published

3 months ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

While shortages have been reduced, supply-chain risks from global conflict may reinforce those calling for greater EU autonomy when it comes to medicine supply.

The MEPs and Council will lock horns for the second trilogue on the Critical Medicines Act. While the Cypriot Presidency has described ongoing discussions as “constructive” with some room for “targeted flexibilities”, other senior diplomats told Vital Signs that there is currently “little appetite for flexibility” from the Council.

One diplomat said: “There is a strong sense that many of the Parliament’s amendments go too far, particularly on issues like the scope of Chapter III [which covers the criteria for recognising strategic projects and their financing], which could hinder investment and distort the focus of the legislation, which is incentivising the supply of critical medicines.”

The Parliament’s amendments seek a broad definition, extending the scope of the act to cover not only critical medicinal products but also “medicinal products of common interest”....

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending